S2Medical ABFRA:S21 OCF Yield % is 25.50 as of Jun. 25, 2026. The stock has 3 warning signs investors should review. Among 852 Medical Devices & Instruments companies, S2Medical AB ranks better than 97.77% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for S2Medical AB's OCF Yield % or its related term are showing as below:
FRA:S21'
s OCF Yield % Range Over the Past 10 Years
Min: -5863.33 Med: -18.71 Max: 603.5
Current: 25.5
During the past 10 years, the highest OCF Yield % of S2Medical AB was 603.50%. The lowest was -5863.33%. And the median was -18.71%.
FRA:S21's OCF Yield % is ranked better than 97.77% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.76
vs FRA:S21: 25.50
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
S2Medical AB OCF Yield % Related Terms
S2Medical AB OCF Yield % Historical Data
* Premium members only.
The historical data trend for S2Medical AB's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:S21 vs ISRG, BDX, MDLN: OCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, S2Medical AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
S2Medical AB OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, S2Medical AB's OCF Yield % distribution charts can be found below:
* The bar in red indicates where S2Medical AB's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
S2Medical AB (FRA:S21) has a OCF Yield % of 25.50 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on S2Medical AB and its competitors. According to the industry distribution chart, S2Medical AB ranks #19 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 2.2%.
Is S2Medical AB's OCF Yield % too high?
S2Medical AB's current OCF Yield % is 25.50. The Medical Devices & Instruments industry median OCF Yield % is 1.76. S2Medical AB's value of 25.50 is 1348.9% above this industry median. Based on the distribution chart, S2Medical AB ranks #19 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does S2Medical AB's OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, S2Medical AB ranks #19 out of 852 companies for OCF Yield %. This places S2Medical AB in the top 2% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.76. S2Medical AB's value of 25.50 is 1348.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.76, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. S2Medical AB's current OCF Yield % of 25.50 is 1348.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on S2Medical AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. S2Medical AB's current OCF Yield % is 25.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S2Medical AB stock overvalued right now?
S2Medical AB (FRA:S21) has a current OCF Yield % of 25.50. The current OCF Yield % is 25.50 and 1348.9% above the Medical Devices & Instruments industry median of 1.76. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For S2Medical AB (FRA:S21), the current OCF Yield % is 25.50 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:S21 has been successfully added to your 